Peer Exchange

A panel of experts on Alzheimer disease discuss the evolving treatment landscape, focusing on cost considerations and the disease’s impact on patients, families, and caregivers.

A panel of experts provide an overview of gene therapy, review recently approved gene therapies for rare diseases such as hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, and discuss managed care considerations, focusing on the growing pipeline of therapies.

A panel of experts dive into the clinical characteristics and heterogeneity of desmoid tumors, the importance of a multidisciplinary approach in both community-based and academic settings, and the profound impact of desmoid tumors on patients' quality of life.

Stephanie L. Graff, MD, provides insights on the evolving treatment landscape in ER+/HER2- metastatic breast cancer, focusing on ESR1 mutations and oral SERDs.

Led by Ryan Haumschild, PharmD, MS, MBA, CPEL, a panel of experts highlight keyoperational considerations for bispecific antibodies in cancer treatment.

Jason Luke, MD, FACP leads a panel of medical experts in a discussion around immunotherapy in the field of Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC).

A panel of medical experts discuss the significance of collaborative care and key considerations in the treatment of myelodysplastic syndrome (MDS).

Medical experts discuss the prevalence of heart failure, current treatment strategies and unmet needs in heart failure management.

Experts discuss the transition from biologics to biosimilars and emphasize the importance of adaptability when non-medical switching occurs.

Clinical pathways considerations and key treatment strategies for hepatocellular carcinoma (HCC) are discussed by a panel of medical experts.

A panel of medical experts hold a discussion surrounding updates in metastatic colorectal cancer.

Hilary Baldwin, MD, Arash Mostaghimi, MD, Steven Feldman, MD, PhD, and Casey Butrus, PharmD, discuss updates in acne therapy and multidisciplinary care for patients.

A panel of experts explore a novel class of medications for patients with metastatic breast cancer, the oral selective estrogen receptor degrader (SERDs).

A panel of medical experts will gather to discuss current and unmet needs in the treatment landscape of schizophrenia.

A panel of medical experts explore CDK 4/6 inhibitors for patients diagnosed with high-risk early breast cancer.

A panel of experts describe the burden of the HIV epidemic including its impacts on patients and payers, review the latest evidence and treatment guidelines informing decision-making in HIV, and discuss unmet needs and future directions in the treatment of HIV.

A panel of medical experts discuss the significance of RSV vaccination.

Ryan Haumschild, PharmD, MS, MBA leads a panel of medical experts in a discussion surrounding the potential role of BTK inhibitors in the treatment of multiple sclerosis.

Medical experts explore the use of bispecifics in the relapsed / refractory myeloma treatment landscape.

A panel of medical experts discuss the current treatment landscape surrounding atopic dermatitis.

A panel of medical experts provide insights on the treatment landscape of Multidrug-Resistant HIV.

A panel of medical experts describe the treatment landscape of Geographic Atrophy.

Experts discuss the disease burden and treatment landscape for age-related macular degeneration (AMD), and diabetic macular edema (DME).

A panel of medical experts provide insights to the treatment landscape surrounding multiple myeloma (MM).

A panel of experts provide an overview of the disease burden associated with leukemia and lymphoma, discuss the current treatment landscape of BTK inhibitors, and offer payer considerations in treatment management.